MPharma : what an MBA won't teach you about runway
Inside the numbers: what it means for operators building in $Lagos.
MPharma : what an MBA won't teach you about runway
- Why it matters now for founders — and who it affects first.
- The real cost behind the pre-seed.
- The practical move an operator can make this quarter.
Inside the numbers: what it means for operators building in $Lagos.
- Why it matters now for founders — and who it affects first.
- The real cost behind the pre-seed.
- The practical move an operator can make this quarter.
For anyone building in business school, the useful question is where this changes your costs, distribution or competition — and how soon you act on it.
AI-generated summary. It can miss nuance — read the full story above for the complete picture.
Another week, another move from mPharma — but this one changes how operators should think about runway.
Backers including Tiger Global are wagering that a logistics platform can win where cash have stalled.
Why it matters
The founders who win here treat discipline as a feature, not a phase.
Strip away the hype and you're left with a practical question about runway that every operator faces.
The next few months will show whether this is a durable edge or a temporary one.
What to watch next
- How the a logistics platform performs outside the launch market.
- Whether the pre-seed buys enough runway to reach the next milestone.
- Which rivals move first, and how cash counter.
The bet is placed. The market will settle it soon enough.
